In the last trading session, 6.27 million shares of the 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) were traded, and its beta was 5.05. Most recently the company’s share price was $1.95, and it changed around $0.5 or 34.48% from the last close, which brings the market valuation of the company to $4.48M. SXTP currently trades at a discount to its 52-week high of $18.36, offering almost -841.54% off that amount. The share price’s 52-week low was $0.70, which indicates that the current value has risen by an impressive 64.1% since then. We note from 60 Degrees Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.16 million shares, with the 3-month average coming to 91.56K.
60 Degrees Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended SXTP as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. 60 Degrees Pharmaceuticals Inc is expected to report earnings per share of -0.65 for the current quarter.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) trade information
Instantly SXTP has showed a green trend with a performance of 34.48% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.9800 on recent trading dayincreased the stock’s daily price by 1.52%. The company’s shares are currently down -84.07% year-to-date, but still up 80.56% over the last five days. On the other hand, 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) is 104.77% up in the 30-day period. We can see from the shorts that 37296.0 shares have been sold at a short interest cover period of 0.34 day(s).
60 Degrees Pharmaceuticals Inc (SXTP) estimates and forecasts
60 Degrees Pharmaceuticals Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -51.58 percent over the past six months and at a 79.42% annual growth rate that is well above the industry average of 16.70%. The year-over-year growth rate is expected to be 145.49%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 234k in revenue for the current quarter. 1 analysts expect 60 Degrees Pharmaceuticals Inc to make 300k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 125.68k and 116.46k respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 86.19%. Forecasts for the next quarter put sales growth at 157.60%.
SXTP Dividends
60 Degrees Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in January.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 10.58% of 60 Degrees Pharmaceuticals Inc shares, and 1.25% of them are in the hands of institutional investors. The stock currently has a share float of 1.40%.
